#
R-Tanna Pediatric Suspension
  • Professionals
  • FDA PI

R-Tanna Pediatric Suspension

Generic name:phenylephrine tannate, chlorpheniramine tannate
Dosage form: oral suspension
Drug class:Upper respiratory combinations

Medically reviewed by Drugs.com. Last updated on Jul 22, 2021.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Description

R-Tanna Pediatric Suspension is an antihistamine/nasal decongestant combination available for oral administration as a Suspension. Each 5 mL (one teaspoonful) of the slate-purple-colored, natural strawberry- artificial currant flavored Suspension contains:

Phenylephrine Tannate 5 mg

Chlorpheniramine Tannate 4.5 mg

Other ingredients: benzoic acid, FD and C Blue No. 1, FD and C Red No. 3, FD and C Red No. 40, FD and C Yellow No. 5 (see Precautions), flavors (natural and artificial), glycerin, kaolin, magnesium aluminum silicate, methylparaben, pectin, purified water, saccharin sodium, sucrose.

Clinical Pharmacology

R-Tanna Pediatric Suspension combines the sympathomimetic decongestant effect of phenylephrine with the antihistamine action of chlorpheniramine.

Indications and Usage

R-Tanna Pediatric Suspension is indicated for symptomatic relief of the coryza and nasal congestion associated with the common cold, sinusitis, allergic rhinitis and other upper respiratory tract conditions. Appropriate therapy should be provided for the primary disease.

Contraindications

R-Tanna Pediatric Suspension is contraindicated for newborns, nursing mothers and patients sensitive to any of the ingredients or related compounds.

Warnings

Use with caution in patients with hypertension, cardiovascular disease, hyperthyroidism, diabetes, narrow angle glaucoma or prostatic, hypertrophy. Use with caution or avoid use in patients taking monoamine oxidase (MAO..